# US 2015/0148239 A1 · Spatial molecular barcoding of in situ nucleic acids

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2015/0148239 A1
- Document ID: US20150148239A1
- Status: Published application
- Kind: A1
- Application number: 14/493,127
- Filed: 2014-09-22
- Published: 2015-05-28
- Earliest claimed: 2013-11-22
- Assignees: Agilent Technologies, Inc.
- Applicants: Agilent Technologies, Inc.
- Inventors: Brian Jon Peter; Robert A. Ach; Alicia Scheffer-Wong; Carolina Caffaro
- Web page: https://patentgrep.com/patent/US20150148239A1

## CPC

- C12Q 1/6841: In situ hybridisation
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

This disclosure provides, among other things, a method for analyzing a planar cellular sample. In some embodiments, the method comprises: (a) indirectly or directly attaching nucleic acid tags to binding sites in a planar cellular sample; (b) contacting the planar cellular sample with a solid support comprising an array of spatially addressed features that comprise oligonucleotides, wherein each oligonucleotide comprises a molecular barcode that identifies the feature in which the oligonucleotides is present; (c) hybridizing the nucleic acid tags, or a copy of the same, with the oligonucleotides to produce duplexes; and (d) extending the oligonucleotides in the duplexes to produce extension products that each comprises (i) a molecular barcode and (ii) a copy of a nucleic acid tag. Other embodiments, e.g., kits and the like, are also described.

## Claims

### Claim 1

A method of sample analysis, comprising:
(a) indirectly or directly attaching nucleic acid tags to binding sites in a planar cellular sample;
(b) contacting the planar cellular sample with a solid support comprising an array of spatially addressed features that comprise oligonucleotides, wherein each oligonucleotide comprises a molecular barcode that identifies the location of the oligonucleotide on the solid support;
(c) hybridizing the nucleic acid tags, or a copy of the same, with said oligonucleotides to produce duplexes; and
(d) extending the oligonucleotides in said duplexes to produce extension products that each comprises (i) a molecular barcode and (ii) a copy of a nucleic acid tag.

### Claim 2 (depends on 1)

The method of claim 1, further comprising:
(e) amplifying the extension products by PCR to produce amplification products.

### Claim 3 (depends on 2)

The method of claim 2, further comprising:
(f) sequencing the amplification products to obtain, for each sequenced amplification product, the sequence of a molecular barcode and the sequence of a nucleic acid tag.

### Claim 4 (depends on 3)

The method of claim 3, further comprising:
(g) constructing an image of the planar cellular sample showing the binding sites for the attached nucleic acid tags, wherein, for each sequenced extension product, the molecular barcode provides spatial coordinates for the associated nucleic acid tag.

### Claim 5 (depends on 4)

The method of claim 4, wherein the image shows the position and abundance of the attachment sites for the nucleic acid tags.

### Claim 6 (depends on 1)

The method of claim 1, wherein said nucleic acid tags are attached to antibodies.

### Claim 7 (depends on 1)

The method of claim 1, wherein said nucleic acid tags are RNA or DNA aptamers.

### Claim 8 (depends on 1)

The method of claim 1, wherein said nucleic acid tags are the product of a proximity ligation assay.

### Claim 9 (depends on 1)

The method of claim 1, wherein the array is made by:
(i) synthesizing the oligonucleotides on a solid support, and
(ii) cleaving the oligonucleotides from the solid support in the gas phase,
thereby producing an array of oligonucleotides that are spatially addressed but not attached to a support.

### Claim 10 (depends on 1)

The method of claim 1, wherein the oligonucleotides have two or more sections separated by cleavable linkages, wherein at least one of the sections comprises said molecular barcode and the sections, when they are cleaved from the array, provide PCR primers that amplify the nucleic acid tags.

### Claim 11 (depends on 1)

The method of claim 1, wherein the oligonucleotides comprise one or more repeats of a sequence of formula X-Y, wherein X is the molecular barcode and Y hybridizes to the nucleic acid tags or the complement thereof.

### Claim 12 (depends on 1)

The method of claim 1, wherein the method comprises (i) copying the nucleic acid tags and (ii) hybridizing the copy of the nucleic acid tags with said oligonucleotides to produce duplexes.

### Claim 13 (depends on 1)

The method of claim 1, further comprising registering the constructed image with an image of the original planar cellular sample.

### Claim 14 (depends on 13)

The method of claim 13, wherein the registering is assisted by register features that were added to the planar cellular sample prior to analysis.

### Claim 15 (depends on 1)

The method of claim 1, wherein said nucleic acid tags, or said oligonucleotides are attached to magnetic beads prior to being removed from the planar cellular sample.

### Claim 16 (depends on 1)

The method of claim 1, wherein said planar cellular sample is an FFPE tissue section.

### Claim 17 (depends on 16)

The method of claim 16, wherein said tissue section is a tissue biopsy.

### Claim 18 (depends on 1)

The method of claim 1, wherein the method comprises indirectly or directly attaching a plurality of different nucleic acid tags to sites in a planar cellular sample, wherein different tags are attached to a plurality of binding agents designed to bind to two or more classes of target molecules, said classes comprising DNA, RNA, proteins, oligosaccharides, and lipids.

### Claim 19

A kit comprising:
(a) a solid support comprising an array of spatially addressed features that comprise oligonucleotides, wherein each oligonucleotide comprises a molecular barcode that identifies the feature in which the oligonucleotide is present, wherein the oligonucleotides are cleavably linked to the solid support; and
(b) a set of binding agents that comprise nucleic acid tags,
wherein the oligonucleotides are complementary to a sequence in the nucleic acid tags or the complement of the same.

### Claim 20 (depends on 19)

The kit of claim 19, wherein the oligonucleotides comprise one or more repeats of a sequence of formula X-Y, wherein X is a molecular barcode and Y hybridizes to a nucleic acid tag or the complement thereof.
